5^th International Conference on Clinical & Experimental Dermatology July 13-15, 2015 New Orleans, USA

The field of esthetic and cosmetic dermatology has gained remarkable interest all over the world. The major advantage of recent years is the high scientific levels of the most significant new developments in techniques and pharmacotherapy and other nonsurgical approaches like Laser resurfacing, Sclerotherapy, Soft tissue augmentation. With an aging population and increasing consumer awareness, demand for high-quality, innovative cosmeceutical products will be on the rise in 2014. In fact, Global Information, an information service company that partners with research firms worldwide, recently released statistics that stated that the global cosmeceuticals market should reach $31.84 billion by 2016. According to another report released by Medical Insight, the total retail sales of home-use devices and disposables are expected to rise by 11.4 percent per year to exceed $1.5 billion in 2017.

This study introduces the readers to most skin disorders, and some common procedures. However, as regards analysis, this study limits itself to prescription and therapeutic drugs for dermatological disorders. Cosmetic and aesthetic procedures, aging disorders, and wound care. BCC’s goal in conducting this study was to understand the current status of the US dermatological therapeutics industry and to assess it in the medium term from 2008 through 2013. We were particularly interested in understanding the future market potential for the current and emerging technologies and products within the dermatological therapeutics industry. This report assesses the available therapeutic procedures for skin, along with the drugs and technologies currently being used for various skin treatments. The role of public agencies, the regulatory environment, and non-governmental stakeholders has also been examined.

It is estimated that 1 in 52 men and 1 in 77 women in the US will be diagnosed with melanoma in their lifetime. Despite the fact that melanoma is one of the most rapidly increasing forms of human cancer, new treatments have been slow in developing and the mortality rate continues to rise. We now know that there are several well-defined risk factors for this form of cancer. Our report contains quantitative and qualitative analytical content, covering the present and future of the global cancer drugs market. Although our report is market-centered, we include medical and technical information. We include analyses of under-met market needs from the present looking forward. GMR Data forecast that Avastin will reach its financial peak by 2018 before losing its patent exclusivity in 2019. The drug is also set to benefit from a potential combination therapy, with EGFL7, for the treatment of colorectal and lung cancer, similar to that of Herceptin and Perjeta.

Dermatopathology is a joint subspecialty of dermatology and pathology and to a lesser extent of surgical pathology that focuses on the study of cutaneous diseases at a microscopic and molecular level. It also encompasses analyses of the potential causes of skin diseases at a basic level. Dermatopathologists work in close association with clinical dermatologists. In fact, most of them are trained primarily in dermatology themselves. Dermatologists are able to recognize most skin diseases based on their appearances, anatomic distributions, and behavior. Sometimes, however, those criteria do not allow a conclusive diagnosis to be made, and a skin biopsy is taken to be examined under the microscope or are subject to other molecular tests. That process reveals the histology of the disease and results in a specific diagnostic interpretation. In some cases, additional specialized testing needs to be performed on biopsies, including immunofluorescence, immunohistochemistry, electron microscopy, flow cytometry, and molecular-pathologic analysis.

A veterinary dermatologist is a veterinarian with expertise in the diagnosis and treatment of animal skin, ear, hair, nail, hoof and mouth disorders. Specifically veterinary dermatologists have significant training and experience in the management of allergic skin disease. Companion animal ownership is continuing to increase. Sixty-two percent of US households now own a companion animal (excluding horses), equating to 72.9 million homes . Many other countries are witnessing higher than ever rates of companion animal ownership, including emerging markets such as Brazil, China, India, Mexico, and Russia. Spending on companion animals is also continuing to increase. In the USA, spending has increased from a total of US$23 billion in 1988 to an estimated US$51 billion in 2011. Around 25% of this spending was on veterinary care (including medicines) and a further 20% on over-the-counter products and supplies, with the remainder on food, accessories, etc. This trend is being mirrored in other countries.